Hannah O. Ajoge

Dr. Hannah O. Ajoge

Western University, London, Ontario, Canada
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
HAHannah O. Ajoge
Hannah O. Ajoge
TRTyler M. Renner
Tyler M. Renner
KBKasandra Bélanger
Kasandra Bélanger
MGMatthew Greig
Matthew Greig
SDSamar Dankar
Samar Dankar
SBStephen Barr
Stephen Barr
APOBEC3 (A3) proteins are host-encoded deoxycytidine deaminases that provide an innate immune barrier to retroviral infection, notably against HIV-1. Low levels of deamination are believed to contribute to the genetic evolution of HIV-1, while intense catalytic activity of these proteins can induce catastrophic hypermutation in proviral DNA leading to near-total HIV-1 restriction. So far, little is known about how A3 cytosine deaminases might impact HIV-1 proviral DNA integration sites in human chromosomal DNA. Using a deep sequencing approach, we analyze the influence of catalytic active and inactive APOBEC3F and APOBEC3G on HIV-1 integration site selections. Here we show that DNA editing is detected at the extremities of the long terminal repeat regions of the virus. Both catalytic active and non-catalytic A3 mutants decrease insertions into gene coding sequences and increase integration sites into SINE elements, oncogenes and transcription-silencing non-B DNA features. Our data implicates A3 as a host factor influencing HIV-1 integration site selection and also promotes what appears to be a more latent expression profile.

14 March 2011 in PLOS ONE
Verified
Journal Article
Open access
PDF file
HAHannah O. Ajoge
Hannah O. Ajoge
MGMichelle L. Gordon
Michelle L. Gordon
TOTulio de Oliveira
Tulio de Oliveira
TGTaryn N. Green
Taryn N. Green
SISani Ibrahim
Sani Ibrahim
TNThumbi Ndung'U
Thumbi Ndung'U
HIV-1 CRF02_AG and subtype G (HIV-1G) account for most HIV infections in Nigeria, but their evolutionary trends have not been well documented. To better elucidate the dynamics of the epidemic in Nigeria we characterised the gag and env genes of North-Central Nigerian HIV-1 isolates from pregnant women. Of 28 samples sequenced in both genes, the predominant clades were CRF02_AG (39%) and HIV-1G (32%). Higher predicted proportion of CXCR4-tropic (X4) HIV-1G isolates was noted compared to CRF02_AG (p = 0.007, Fisher's exact test). Phylogenetic and Bayesian analysis conducted on our sequences and all the dated available Nigerian sequences on the Los Alamos data base showed that CRF02_AG and HIV-1G entered into Nigeria through multiple entries, with presence of HIV-1G dating back to early 1980s. This study underlines the genetic complexity of the HIV-1 epidemic in Nigeria, possible subtype-specific differences in co-receptor usage, and the evolutionary trends of the predominant HIV-1 strains in Nigeria, which may have implications for the design of biomedical interventions and better understanding of the epidemic.

1 January 2012 in AIDS Research and Human Retroviruses
Verified
Journal Article
Closed access
HAHannah O. Ajoge
Hannah O. Ajoge
MGMichelle L. Gordon
Michelle L. Gordon
SISani Ibrahim
Sani Ibrahim
OSOladapo S. Shittu
Oladapo S. Shittu
TNThumbi Ndung'U
Thumbi Ndung'U
SOStephen O. Olonitola
Stephen O. Olonitola
In Nigeria, the country with the second largest number of HIV-1-infected people globally, antiretroviral therapy rollout is now widespread with an increasing number of individuals and communities benefitting. However, the drug resistance profile of patients initiating or failing on antiretroviral therapy is not well characterized. Here we studied the molecular variability of the protease and reverse transcriptase region of isolates from therapy-naive pregnant women in North-Central Nigeria (one of the geopolitical zones with the highest prevalence of HIV in Nigeria) to identify baseline mutations with potential drug resistance implications. We observed the predominance of CRF02_AG and subtype G in the North-Central Nigerian epidemic and the presence of both primary and secondary drug resistance mutations. Contrary to observation from other geopolitical zones, a decreased frequency of reverse transcriptase mutations/polymorphisms was observed, thus suggesting regional differences in level of transmitted drug resistance that require more study.

11 November 2022 in Viruses
Verified
Journal Article
Open access
PDF file
HAHannah O. Ajoge
Hannah O. Ajoge
HKHinissan P. Kohio
Hinissan P. Kohio
EPErmela Paparisto
Ermela Paparisto
MCMacon D. Coleman
Macon D. Coleman
KWKemen Wong
Kemen Wong
SBStephen Barr
Stephen Barr
The integration of the HIV-1 genome into the host genome is an essential step in the life cycle of the virus and it plays a critical role in the expression, long-term persistence, and reactivation of HIV expression. To better understand the local genomic environment surrounding HIV-1 proviruses, we assessed the influence of non-canonical B-form DNA (non-B DNA) on the HIV-1 integration site selection. We showed that productively and latently infected cells exhibit different integration site biases towards non-B DNA motifs. We identified a correlation between the integration sites of the latent proviruses and non-B DNA features known to potently influence gene expression (e.g., cruciform, guanine-quadruplex (G4), triplex, and Z-DNA). The reactivation potential of latent proviruses with latency reversal agents also correlated with their proximity to specific non-B DNA motifs. The perturbation of G4 structures in vitro using G4 structure-destabilizing or -stabilizing ligands resulted in a significant reduction in integration within 100 base pairs of G4 motifs. The stabilization of G4 structures increased the integration within 300–500 base pairs from G4 motifs, increased integration near transcription start sites, and increased the proportion of latently infected cells. Moreover, we showed that host lens epithelium-derived growth factor (LEDGF)/p75 and cleavage and polyadenylation specificity factor 6 (CPSF6) influenced the distribution of integration sites near several non-B DNA motifs, especially G4 DNA. Our findings identify non-B DNA motifs as important factors that influence productive and latent HIV-1 integration and the reactivation potential of latent proviruses.

1 June 2009
Verified
Journal Article
Closed access
GPGrace Pennap
Grace Pennap
GAGinikanwa Amauche
Ginikanwa Amauche
HAHannah O. Ajoge
Hannah O. Ajoge
SGSarah Gabadi
Sarah Gabadi
SASimon Agwale
Simon Agwale
JFJoseph Forbi
Joseph Forbi

7 February 2023 in Viruses
Verified
Journal Article
Open access
PDF file
HKHinissan P. Kohio
Hinissan P. Kohio
HAHannah O. Ajoge
Hannah O. Ajoge
MCMacon D. Coleman
Macon D. Coleman
Emmanuel NdashimyeEmmanuel Ndashimye
Emmanuel Ndashimye
RGRichard Gibson
Richard Gibson
SBStephen Barr
Stephen Barr
Retroviral integration site targeting is not random and plays a critical role in expression and long-term survival of the integrated provirus. To better understand the genomic environment surrounding retroviral integration sites, we performed a meta-analysis of previously published integration site data from evolutionarily diverse retroviruses, including new experimental data from HIV-1 subtypes A, B, C and D. We show here that evolutionarily divergent retroviruses exhibit distinct integration site profiles with strong preferences for integration near non-canonical B-form DNA (non-B DNA). We also show that in vivo-derived HIV-1 integration sites are significantly more enriched in transcriptionally silent regions and transcription-silencing non-B DNA features of the genome compared to in vitro-derived HIV-1 integration sites. Integration sites from individuals infected with HIV-1 subtype A, B, C or D viruses exhibited different preferences for common genomic and non-B DNA features. In addition, we identified several integration site hotspots shared between different HIV-1 subtypes, all of which were located in the non-B DNA feature slipped DNA. Together, these data show that although evolutionarily divergent retroviruses exhibit distinct integration site profiles, they all target non-B DNA for integration. These findings provide new insight into how retroviruses integrate into genomes for long-term survival.